Israel’s BiondVax has just received a 4.87 million shekels grant from Israel’s Chief Scientist, to allow them continue development of their universal influenza vaccine M-001. The treatment is in advanced trials and the funds will prepare it for commercialization.
http://www.globes.co.il/en/article-chief-scientist-grants-biondvax-nis-487m-1000970349